Salivary gland tumors treated with adjuvant intensity-modulated radiotherapy with or without concurrent chemotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 1, 2012, Pages 308-314

  Schoenfeld, Jonathan D ^a   Sher, David J ^b   Norris Jr , Charles M ^b   Haddad, Robert I ^b,c   Posner, Marshall R ^b,c   Balboni, Tracy A ^b   Tishler, Roy B ^b  

^a HARVARD RADIATION ONCOLOGY PROGRAM   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Adenoid cystic carcinoma; Chemoradiotherapy; Intensity modulated radiotherapy; Mucoepidermoid carcinoma; Salivary gland cancers

Indexed keywords

ADENOID CYSTIC CARCINOMA; CHEMORADIOTHERAPY; INTENSITY-MODULATED RADIOTHERAPY; MUCOEPIDERMOID CARCINOMA; SALIVARY GLANDS;

CHEMOTHERAPY; DISEASES; DOSIMETRY; PATIENT MONITORING; RADIOTHERAPY; TOXICITY; TUMORS;

PHYSICAL THERAPY;

CARBOPLATIN; CISPLATIN; PACLITAXEL; TRASTUZUMAB;

ACINAR CELL CARCINOMA; ADENOCARCINOMA; ADENOID CYSTIC CARCINOMA; ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER STAGING; CHEMORADIOTHERAPY; CLINICAL ARTICLE; DERMATITIS; DISEASE COURSE; DISEASE FREE SURVIVAL; DISTANT METASTASIS; EAR DISEASE; ESOPHAGITIS; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTENSITY MODULATED RADIATION THERAPY; MALE; MUCOSA INFLAMMATION; OVERALL SURVIVAL; PALATE; PAROTID GLAND; PRIORITY JOURNAL; RADIATION DOSE; RETROSPECTIVE STUDY; SALIVARY GLAND TUMOR; SUBMANDIBULAR GLAND; TONGUE; TREATMENT DURATION;

ADENOCARCINOMA; AGED; ANTINEOPLASTIC AGENTS; CARBOPLATIN; CARCINOMA, ADENOID CYSTIC; CARCINOMA, MUCOEPIDERMOID; CHEMORADIOTHERAPY; DERMATITIS; DISEASE-FREE SURVIVAL; ESOPHAGITIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUCOSITIS; PACLITAXEL; PROGNOSIS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; SALIVARY GLAND NEOPLASMS; XEROSTOMIA;

EID: 83955165992     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.09.042     Document Type: Article

References (25)

1. E.C. Sun, R. Curtis, and M. Melbye Salivary gland cancer in the United States Cancer Epidemiol Biomarkers Prev 8 1999 1095 1100
2. J.G. Armstrong, L.B. Harrison, and R.H. Spiro Malignant tumors of major salivary gland origin: A matched-pair analysis of the role of combined surgery and postoperative radiotherapy Arch Otolaryngol Head Neck Surg 116 1990 290 293
3. A.M. Chen, M.K. Bucci, and V. Weinberg Adenoid cystic carcinoma of the head and neck treated by surgery with or without postoperative radiation therapy: Prognostic features of recurrence Int J Radiat Oncol Biol Phys 66 2006 152 159
4. D.R. Gomez, B.S. Hoppe, and S.L. Wolden Outcomes and prognostic variables in adenoid cystic carcinoma of the head and neck: A recent experience Int J Radiat Oncol Biol Phys 70 2008 1365 1372
5. C.H.J. Terhaard, H. Lubsen, and C. Rasch The role of radiotherapy in the treatment of malignant salivary gland tumors Int J Radiat Oncol Biol Phys 61 2005 103 111
6. A.S. Garden, R.S. Weber, and W.H. Morrison The influence of positive margins and nerve invasion in adenoid cystic carcinoma of the head and neck treated with surgery and radiation Int J Radiat Oncol Biol Phys 32 1995 619 626
7. J. Bernier, C. Domenge, and M. Ozsahin Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer N Engl J Med 350 2004 1945 1952
8. J.S. Cooper, T.F. Pajak, and A.A. Forastiere Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck N Engl J Med 350 2004 1937 1944
9. A.A. Forastiere, H. Goepfert, and M. Maor Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer N Engl J Med 349 2003 2091 2098
10. G. Fountzilas, E. Ciuleanu, and U. Dafni Concomitant radiochemotherapy vs radiotherapy alone in patients with head and neck cancer: A Hellenic Cooperative Oncology Group phase III study Med Oncol 21 2004 95 107
11. N.Y. Lee, F.F. De Arruda, and D.R. Puri A comparison of intensity-modulated radiation therapy and concomitant boost radiotherapy in the setting of concurrent chemotherapy for locally advanced oropharyngeal carcinoma Int J Radiat Oncol Biol Phys 66 2006 966 974
12. J.P. Pignon, J. Bourhis, C. Domenge for the MACH-NC (Meta-Analysis of Chemotherapy on Head and Neck Cancer) Collaborative Group Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data Lancet 355 2000 949 955
13. M.W. Münter, D. Schulz-Ertner, and H. Hof Inverse planned stereotactic intensity modulated radiotherapy (IMRT) in the treatment of incompletely and completely resected adenoid cystic carcinomas of the head and neck: Initial clinical results and toxicity of treatment Radiat Oncol 1 2006 17
14. T. Tanvetyanon, D. Qin, and T. Padhya Outcomes of postoperative concurrent chemoradiotherapy for locally advanced major salivary gland carcinoma Arch Otolaryngol Head Neck Surg 135 2009 687 692
15. B. Glisson, A.D. Colevas, and R. Haddad HER2 expression in salivary gland carcinomas: dependence on histological subtype Clin Cancer Res 10 2006 944 946
16. A.M. Chen, M.K. Bucci, and J.M. Quivey Long-term outcome of patients treated by radiation therapy alone for salivary gland carcinomas Int J Radiat Oncol Biol Phys 66 2006 1044 1050
17. E. Hocwald, H. Korkmaz, and G.H. Yoo Prognostic factors in major salivary gland cancer Laryngoscope 111 2001 1434 1439
18. R.I. Haddad, M.R. Posner, and P.M. Busse Chemoradiotherapy for adenoid cystic carcinoma: Preliminary results of an organ sparing approach Am J Clin Oncol 29 2006 153 157
19. M.R. Posner, T.J. Ervin, and R.R. Weichselbaum Chemotherapy of advanced salivary gland neoplasms Cancer 50 1982 2261 2264
20. A.I. Dreyfuss, J.R. Clark, and B.G. Fallon Cyclophosphamide, Adriamycin and cisplatin combination chemotherapy for advanced carcinomas of salivary gland origin Cancer 60 1987 2869 2872
21. M. Airoldi, C. Bumma, and O. Bertetto Vinorelbine treatment of recurrent salivary gland carcinomas Bull Cancer 85 1998 892 894
22. M. Airoldi, G. Fornari, and F. Pedani Paclitaxel and carboplatin for recurrent salivary gland malignancies Anticancer Res 20 2000 3781 3783
23. J. Gilbert, Y. Li, and H.A. Pinto Phase II trial of Taxol in salivary gland malignancies (E1394): A trial of the Eastern Cooperative Oncology Group Head Neck 28 2006 197 204
24. R.I. Haddad, A.D. Colevas, and J.F. Krane Herceptin in patients with advanced or metastatic salivary gland carcinomas: A phase II study Oral Oncol 39 2003 724 727
25. W.M. Mendenhall, C.G. Morris, and R.J. Amdur Radiotherapy alone or combined with surgery for salivary gland carcinoma Cancer 103 2005 2544 2550